Glucose Health, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.364022 million compared to USD 0.287103 million a year ago. Net loss was USD 0.110828 million compared to USD 0.155404 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the six months, sales was USD 0.577835 million compared to USD 0.524568 million a year ago. Net loss was USD 0.301877 million compared to USD 0.144981 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.